Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Vanda Pharmaceuticals Inc. VNDA: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year ...

The semiconductor manufacturing equipment specialist reported record revenues in its fiscal 2024 fourth quarter.

Digi International (DGII) delivered earnings and revenue surprises of 4% and 0.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Coca-Cola (KO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Tower Semiconductor Ltd (NASDAQ: TSEM) reported a fiscal third-quarter 2024 revenue growth of 3.4% year-on-year to $370.51 ...

Lyell Immunopharma (LYEL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

Bilibili (BILI) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.29 per share a year ago. These figures are ...

EVgo Inc (NASDAQ:EVGO) shares are trading higher after the company reported third-quarter sales growth of 92% year-on-year to ...

It reported adjusted earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.87. The bottom line, however, declined from $3.04 recorded in the year-ago period. Consolidated net ...